SEC Form 4 · accession 0000899243-19-000964
Zymeworks Inc. · ZYME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony J. Polverino
Officer — Chief Scientific Officer
Period of report
Jan 8, 2019
Accepted (ET)
Jan 10, 2019 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403752
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.53 | Jan 8, 2019 | A | 75,000 | A | — | Jan 7, 2029 | Common Shares | 75,000 | 75,000 | D |
Explanation of responses
- F1Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.